Nebenwirkungen · Savene
Savene 20 mg/ml powder and solvent for concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 5–6
HOS-208629 · Präparat HOS-154145
5 System Organ Classes (SOC) Frequency Adverse reactions Infections and infestations Very common Postoperative infection Common Infection Neutropenic infection Immune system disorders Not known Anaphylactic reactions Not known Hypersensitivity Metabolism and nutrition disorders Common Decreased appetite Nervous system disorders Common Dizziness Sensory loss Syncope Tremor Vascular disorders Common Phlebitis Superficial thrombophlebitis Venous thrombosis limb Respiratory, thoracic and mediastinal Common Dyspnoea disorders Pneumonia Gastrointestinal disorders Very common Nausea Common Vomiting Diarrhoea Stomatitis Dry mouth Skin and subcutaneous tissue Common Alopecia disorders Pruritus Musculoskeletal and connective Common Myalgia tissue disorders Reproductive system and breast Common Vaginal haemorrhage disorders General disorders and administration Very common Injection site pain site conditions Common Pyrexia Injection site phlebitis Injection site erythema Fatigue Injection site induration Injection site swelling Peripheral oedema Somnolence Investigations Common Weight decreased Injury, poisoning and procedural Common Wound complication complications
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-09-06T02:00:00Z · SHA-256 03ad60d30f6868bb116937dbef5ce0b32c0dc2bb4b4d32174d098c462660e73f · Passage ad4d484a2494b9d993ae1341597296220c1cfa06c2a57126cd55c34c2d822c23 · Zeichen 1382–3950 im Abschnitt